Lixte Biotechnology: Agreement to Conduct a Phase 1B/2 Clinical Trial of Lb-100, Combined With Atezolizumab for Patients With Metastatic Colon Cancer
Lixte生物科技:與Atezolizumab合用對轉移性結直腸癌患者進行Lb-100的1B/2期臨床試驗協議
Lixte Biotechnology: Agreement to Conduct a Phase 1B/2 Clinical Trial of Lb-100, Combined With Atezolizumab for Patients With Metastatic Colon Cancer
Lixte生物科技:與Atezolizumab合用對轉移性結直腸癌患者進行Lb-100的1B/2期臨床試驗協議
譯文內容由第三人軟體翻譯。